Keywords: aacr, meeting, immunogen, hn901-dm1, reported, preclinical, studies

AACR Meeting: ImmunoGen's hN901-DM1

Article | 21 April 1997

Print This

- ImmunoGen has reported that preclinical studies with its "humanized"antibody, hN901-DM1, have shown that, at a dose of 300mcg/ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in